Previous studies demonstrated that FOXK2 suppressed the growth of lung cancer cells by targeting cyclin D1 and CDK4 (Chen et al., 2017) and also influenced CDKs, which linked it to the regulation of the cell cycle (Marais et al., 2010). Here, CDK4 is linked to lung cancer.